Literature DB >> 33879081

Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study.

R P Willink1, Rimke C Vos1,2, I Looijmans-van den Akker3, Huberta E Hart4,5.   

Abstract

BACKGROUND: Type 2 diabetes (T2DM) and COPD are chronic medical conditions, for which patients need lifelong healthcare. The aim of this study is to examine in which healthcare setting patients with T2DM and COPD receive their care, and if this is the correct healthcare setting according to guidelines.
METHOD: T2DM and COPD patients from five primary care practices were included. Data concerning healthcare setting and patient- and clinical characteristics were extracted from the electronic medical records. Patient profiles treated in primary care were compared with the profiles of those treated in secondary care. In patients treated in secondary care we evaluated whether treatment allocation was according to the guidelines and if back-referral to primary care should take place.
RESULTS: Of the T2DM and COPD patients 7.6% and 29.6% respectively, were treated in secondary care, and 72.7% respectively 31.4% of these were according to the guideline. T2DM patients treated in primary care were older (63 versus 57 years, p < 0.01, had a shorter diabetes duration (8 versus 11 years, p < 0.01) and lower HbA1c (53.0 versus 63.5 mmol/l, p < 0.01) than those treated in secondary care. Those with COPD treated in primary care used less inhalation medication (75.2 versus 90.1%, p < 0.01) and had better spirometry results (67.39 versus 57.53 FEV1%pred, p < 0.01).
CONCLUSION: The majority of the patients with T2DM and COPD were correctly treated in primary care and on average patients with a better health condition were treated in primary care.. Also, those who were treated in secondary care were most of the time treated in the correct treatment setting according to the guidelines.

Entities:  

Keywords:  Chronic obstructive; Diabetes mellitus; Primary health care; Pulmonary disease; Type 2

Year:  2021        PMID: 33879081     DOI: 10.1186/s12875-021-01424-w

Source DB:  PubMed          Journal:  BMC Fam Pract        ISSN: 1471-2296            Impact factor:   2.497


  3 in total

1.  Chronic Obstructive Pulmonary Disease: Diagnosis and Management.

Authors:  Shari Gentry; Barry Gentry
Journal:  Am Fam Physician       Date:  2017-04-01       Impact factor: 3.292

Review 2.  The global burden of diabetes and its complications: an emerging pandemic.

Authors:  Susan van Dieren; Joline W J Beulens; Yvonne T van der Schouw; Diederick E Grobbee; Bruce Neal
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-05

3.  Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Authors:  Rhys Williams; Suvi Karuranga; Belma Malanda; Pouya Saeedi; Abdul Basit; Stéphane Besançon; Christian Bommer; Alireza Esteghamati; Katherine Ogurtsova; Ping Zhang; Stephen Colagiuri
Journal:  Diabetes Res Clin Pract       Date:  2020-02-13       Impact factor: 5.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.